ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding ProQR Therapeutics N.V. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 47 | 49 | +2 |
| Shares | 18.4M | 17.4M | −1.00M (−5.5%) |
| Value | $37.0M | $39.8M | +$2.82M (+7.6%) |
New holders (4)
Institutions that held ProQR Therapeutics N.V. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RFG Advisory, LLC | 32,000 | $73.3K | 0.00% |
| Acadian Asset Management LLC | 24,763 | $56.0K | 0.00% |
| Occudo Quantitative Strategies LP | 12,053 | $27.6K | 0.00% |
| EP Wealth Advisors, LLC | 11,500 | $26.3K | 0.00% |
Sold out (2)
Institutions that held ProQR Therapeutics N.V. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Marshall Wace, LLP | 10,085 | $20.0K |
| Tower Research Capital LLC (TRC) | 3,536 | $7.00K |